Crossmark

Limited efficacy of high-dose methotrexate in patients with neurolymphomatosis

Crossref DOI link: https://doi.org/10.1007/s12185-018-02586-7

Published Online: 2019-01-03

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobayashi, Hiroki https://orcid.org/0000-0001-7892-4674
Abe, Yoshiaki

Miura, Daisuke

Narita, Kentaro

Kitadate, Akihiro

Takeuchi, Masami

Matsue, Kosei
License Information

Text and Data Mining valid from 2019-01-03
More Information

Article History

Received: 23 October 2018

Revised: 26 December 2018

Accepted: 26 December 2018

First Online: 3 January 2019

Compliance with ethical standards

:

: The authors declare no competing financial interests.

: All procedures involving human participants in this study were in accordance with the ethical standards of the institutional and national research committee as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.